Page 5 - Pharma

Unichem gets USFDA nod for generic version of tolterodine tartrate tablets

The tolterodine tartrate tablets are generic versions of Pfizer Inc's DETROL tablets

Why are cheaper Covid-19 drugs not being promoted, asks Parliamentary panel

Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for Covid-19 treatment

India's Sovereign Pharma dispatches first batch of remdesivir to Cipla

Privately held Sovereign Pharma is manufacturing and packaging Cipla's remdesivir version

First Covid-19 vaccine to reach phase-1 trial is safe, say researchers

Several teams across the world are in a race to develop a vaccine for coronavirus infection

Coronavirus: Eli Lilly starts testing; Gilead drug shows positive signs

Lilly said it currently does not anticipate shortages for any of its medicines, including baricitinib

Glenmark gets tentative nod from USFDA for generic type-2 diabetes tablets

The product is a generic version of AstraZeneca AB's Farxiga tablets

Here's how common mental shortcuts can cause major physician errors

In health care, unconscious biases can lead to disparate treatment of patients and can affect whether similar patients live or die

Govt asks pharma groups to ensure companies follow ethical practices

The DoP drafted the UCPMP has been voluntarily followed by drug firms since 2015., however, the code is not mandatory

Drugmakers slash prices to be eligible for China's bulk-buy program

Sale prices of over 100 types of commonly used drugs are on average about 17 to 18 times of their manufacturing costs, the statement said

Ready with the innovation edge

Global capability centres will drive innovation for the global enterprise

Q3 results preview: US regulatory overhang on earnings of pharma firms

The US is Indian pharma's largest export market and Indian drugmakers account for a little over 30 per cent of generic drugs sold in that country

Gene therapy to conquering hepatitis C: A decade of medical breakthroughs

Putting aside prices for a moment, it's been an exciting period for medical progress

NITI Aayog plans to bring all medical devices under one regulatory regime

The NITI Aayog has proposed to do away with the need to have manufacturing licences to register a medical device

Pharma sector likely to grow at 10-12% during FY19-22, outlook stable: Icra

Icra cited abating headwinds from pricing pressure in the US, stable growth for the Indian market driven by increasing healthcare spending

Price hike, at last

Govt should not control drug prices

Ceiling prices of 21 key medicines raised by 50%; NPPA invokes DPCO 2013

The prices of APIs have gone up in the range of 5-88%

Stricter regulations, pricing control slow down pharma sector growth

The fifth part of the series looks at what's ailing the pharma sector

Aurobindo recalls heartburn drug ranitidine, two others from US market

Development follows regulatory compliance issues being faced by several of its plants back home; Ranitidine taken off due to the presence of carcinogenic compound

Dr Reddy's launches cancer treatment drug Bortezomib in the US market

Bortezomib is an active ingredient similar to that of the once blockbuster cancer treatment Velcade of Millennium Pharmaceuticals

MedLife's secret sauce behind delivering medicines in less than 2 hours

MedLife has mobile apps for everyone, and a smartphone is where all the tasks happen